Could bradykinin pathway inhibition change the course of severe hantavirus disease?
Immunology Letters · 2026-10 · 281 · 107201
DOI: 10.1016/j.imlet.2026.107201 ↗Kurz gefasst
Leserbrief in der Zeitschrift Immunology Letters, 2026-10. Verfasst von Marina Weerheim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Doctor Internal Medicine, Groene Hart Hospital, Gouda, the Netherlands. Hauptthemen laut MEDLINE: Bradykinin, Hantavirus Infections, Orthohantavirus. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Doctor Internal Medicine, Groene Hart Hospital, Gouda, the Netherlands.
- Internist-immunologist and allergist, department of Internal Medicine, Groene Hart Hospital, Gouda, the Netherlands. Electronic address: faiz.karim@ghz.nl.
Zitieren
APA
Weerheim, M., & Karim, F. (2026). Could bradykinin pathway inhibition change the course of severe hantavirus disease?. Immunology Letters, 281, 107201. https://doi.org/10.1016/j.imlet.2026.107201
Vancouver
Weerheim M, Karim F. Could bradykinin pathway inhibition change the course of severe hantavirus disease?. Immunology Letters. 2026;281:107201. doi:10.1016/j.imlet.2026.107201
BibTeX
@article{Weerheim2026,
author = {Weerheim, Marina and Karim, Faiz},
title = {Could bradykinin pathway inhibition change the course of severe hantavirus disease?},
journal = {Immunology Letters},
year = {2026},
volume = {281},
pages = {107201},
doi = {10.1016/j.imlet.2026.107201}
}
EUVIMED